MAPPING GENETIC HEART DISEASES

PLN. Our heart muscle disease belongs to the group of rare heart diseases that can have serious consequences for over thousands of gene carriers in the Netherlands and abroad. As a patient, you are looking for the best possible care, an accurate diagnosis and the proper (more…)
More

HELP SCIENTISTS TO UNDERSTAND

The PHOspholamban RElated CArdiomyopathy STudy (PHORECAST) aims to investigate several aspects of the PLN p.Arg14del mutation and the carriers of this gene mutation. Some of these research projects include PLN p.Arg14del mutation carriers and (more…)
More

PLN RESEARCH PROJECT 2017-2022

The transatlantic project The PLN disease is a currently uncurable heart muscle disease caused by a genetic mutation in the DNA. Carriers of this mutation are exposed to a major health risk which may express itself in moderate to very serious heart failure, arrhythmias and sudden premature death. (more…)
More

VENTRICULAR ASSIST DEVICE: A MIRACLE OF TECHNOLOGY

When suffering from serious heart failure, some patients get to a point after a long disease process at which the treatment method with drugs reaches a "dead end". The heart is so sick by then and has already lost so much of its pumping strength that the patient starts to accumulate fluid around the heart, abdomen, legs and elsewhere in the body. (more…)
More

ENTRESTO: NEW DRUG FOR HEART FAILURE

A recent large study has shown that the new drug Entresto has a very positive effect on patients with heart failure: patients are able to live longer and are less often hospitalized due to heart failure. This is probably a medical progression in the treatment of chronic heart failure. (more…)
More